Literature DB >> 10209661

Cardiovascular autonomic nervous system dysfunction in patients with rheumatoid arthritis and systemic lupus erythematosus.

W Louthrenoo1, P Ruttanaumpawan, A Aramrattana, W Sukitawut.   

Abstract

Although peripheral and central nervous system involvement have been well recognized in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), autonomic nervous system (ANS) involvement has rarely been studied, and has shown conflicting results. We performed cardiovascular ANS assessment in 34 RA and 37 SLE patients, using standard cardiovascular reflex tests. The results in each patient were compared with age- and sex-matched healthy controls. Forty-seven percent of the RA patients and 19% of the SLE patients had symptoms suggesting ANS dysfunction. The heart rate variation in response to deep breathing was significantly decreased in both the RA and SLE patients (p = 0.001). This diminished heart rate response showed no correlation with the disease duration, the number of swollen joints, the Ritchie articular index, ESR, or rheumatoid factor in the RA group, or the disease duration, the SLEDAI score or ESR in the SLE group. The clinical significance of the diminished cardiovascular ANS response needs to be investigated.

Entities:  

Mesh:

Year:  1999        PMID: 10209661     DOI: 10.1093/qjmed/92.2.97

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  30 in total

1.  Autonomic nervous system function in rheumatoid arthritis.

Authors:  Miroslav Vlcek; Jozef Rovensky; Graeme Eisenhofer; Zofia Radikova; Adela Penesova; Jana Kerlik; Richard Imrich
Journal:  Cell Mol Neurobiol       Date:  2012-02-05       Impact factor: 5.046

2.  Effect of acute sleep deprivation on heart rate recovery in healthy young adults.

Authors:  Altug Cincin; Ibrahim Sari; Mustafa Oğuz; Sena Sert; Mehmet Bozbay; Halil Ataş; Beste Ozben; Kursat Tigen; Yelda Basaran
Journal:  Sleep Breath       Date:  2014-10-16       Impact factor: 2.816

3.  R-R interval variation and sympathetic skin response in systemic lupus erythematosus.

Authors:  Aslan Tekatas; Süleyman Serdar Koca; Demet Deniz Tekatas; Feyza Aksu; Yüce Dogru; Omer Nuri Pamuk
Journal:  Clin Rheumatol       Date:  2013-09-22       Impact factor: 2.980

4.  Activation of the cholinergic antiinflammatory pathway ameliorates obesity-induced inflammation and insulin resistance.

Authors:  XianFeng Wang; ZhengGang Yang; Bingzhong Xue; Hang Shi
Journal:  Endocrinology       Date:  2011-01-14       Impact factor: 4.736

Review 5.  Restoring the balance of the autonomic nervous system as an innovative approach to the treatment of rheumatoid arthritis.

Authors:  Frieda A Koopman; Susanne P Stoof; Rainer H Straub; Marjolein A Van Maanen; Margriet J Vervoordeldonk; Paul P Tak
Journal:  Mol Med       Date:  2011-05-20       Impact factor: 6.354

6.  Pupillary autonomic dysfunction in patients with ANCA-associated vasculitis.

Authors:  Philipp Moog; O Eren; S Kossegg; K Valda; A Straube; M Grünke; H Schulze-Koops; M Witt
Journal:  Clin Auton Res       Date:  2017-09-01       Impact factor: 4.435

Review 7.  Not all neuropathy in diabetes is of diabetic etiology: differential diagnosis of diabetic neuropathy.

Authors:  Roy Freeman
Journal:  Curr Diab Rep       Date:  2009-12       Impact factor: 4.810

Review 8.  Enhanced pain perception in rheumatoid arthritis: novel considerations.

Authors:  Patrick B Wood
Journal:  Curr Pain Headache Rep       Date:  2009-12

9.  Assessment of autonomic function in a cohort of patients with ANCA-associated vasculitis.

Authors:  P Moog; O Eren; M Witt; V Rauschel; S Kossegg; A Straube; M Grünke; H Schulze-Koops
Journal:  Clin Auton Res       Date:  2016-07-01       Impact factor: 4.435

10.  Cholinergic anti-inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritis.

Authors:  Richard S Goldstein; Annette Bruchfeld; Lihong Yang; Abdul R Qureshi; Margot Gallowitsch-Puerta; Nirav B Patel; Brett J Huston; Sangeeta Chavan; Mauricio Rosas-Ballina; Peter K Gregersen; Christopher J Czura; Richard P Sloan; Andrew E Sama; Kevin J Tracey
Journal:  Mol Med       Date:  2007 Mar-Apr       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.